112 related articles for article (PubMed ID: 3610710)
41. [Modification of the action of ionizing radiation on cells of transplantable tumors by administering xanthobine].
Volchkov VA; Mikhaĭlova NIa; Klimovich VB
Radiobiologiia; 1985; 25(1):112-4. PubMed ID: 3975364
[TBL] [Abstract][Full Text] [Related]
42. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
Denekamp J; Harris SR
Radiat Res; 1976 Apr; 66(1):66-75. PubMed ID: 1257411
[No Abstract] [Full Text] [Related]
43. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
[TBL] [Abstract][Full Text] [Related]
44. [The radiation sensitizing activity of metronidazole and iso-metronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole)].
Proskurjakov SJ; Smoryzanova OA; Rjabcenko NI; Dedenkov AN
Radiobiol Radiother (Berl); 1990; 31(6):531-6. PubMed ID: 2101458
[TBL] [Abstract][Full Text] [Related]
45. Aerobic radiosensitization by SR 4233 in vitro and in vivo.
Zeman EM; Lemmon MJ; Brown JM
Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):125-32. PubMed ID: 2298615
[TBL] [Abstract][Full Text] [Related]
46. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
Hishikawa-Itoh Y; Kato T; Niwa T; Ayakawa Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1243-8. PubMed ID: 2794648
[TBL] [Abstract][Full Text] [Related]
47. Tumor radiosensitization with concomitant bone marrow radioprotection: a study in mice using diethyldithiocarbamate (DDC) under oxygenated and hypoxic conditions.
Evans RG
Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1163-9. PubMed ID: 2987165
[TBL] [Abstract][Full Text] [Related]
48. Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts.
Gurtner K; Ebert N; Pfitzmann D; Eicheler W; Zips D; Baumann M; Krause M
Radiat Oncol; 2014 Dec; 9():261. PubMed ID: 25444177
[TBL] [Abstract][Full Text] [Related]
49. Interaction of tomudex with radiation in vitro and in vivo.
Teicher BA; Ara G; Chen YN; Recht A; Coleman CN
Int J Oncol; 1998 Sep; 13(3):437-42. PubMed ID: 9683775
[TBL] [Abstract][Full Text] [Related]
50. [Radiosensitizing effects of Lycium barbarum polysaccharide for Lewis lung cancer].
Lu CX; Cheng BQ
Zhong Xi Yi Jie He Za Zhi; 1991 Oct; 11(10):611-2, 582. PubMed ID: 1806310
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
Wilson WR; Li AE; Cowan DS; Siim BG
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):905-8. PubMed ID: 9845119
[TBL] [Abstract][Full Text] [Related]
52. The therapeutic advantage of combined X-rays and melphalan.
Joiner MC; Bremner JC; Denekamp J
Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):385-92. PubMed ID: 6706732
[TBL] [Abstract][Full Text] [Related]
53. Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft.
Joschko MA; Webster LK; Bishop JF; Groves J; Yuen K; Olver IN; Narayan KN; Ball DL
Cancer Chemother Pharmacol; 1997; 40(6):534-9. PubMed ID: 9332470
[TBL] [Abstract][Full Text] [Related]
54. Platinum levels in murine tumor following intraperitoneal administration of cisplatin or paraplatin.
Douple EB; Totten MD; Spencer F
NCI Monogr; 1988; (6):129-32. PubMed ID: 3281028
[TBL] [Abstract][Full Text] [Related]
55. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
56. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
Rockwell S; Mate TP; Irvin CG; Nierenburg M
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
[TBL] [Abstract][Full Text] [Related]
57. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine.
Doiron A; Yapp DT; Olivares M; Zhu JX; Lehnert S
Cancer Res; 1999 Aug; 59(15):3677-81. PubMed ID: 10446981
[TBL] [Abstract][Full Text] [Related]
58. The effect of glutathione (GSH) depletion in vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508.
Kramer RA; Soble M; Howes AE; Montoya VP
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1325-9. PubMed ID: 2523885
[TBL] [Abstract][Full Text] [Related]
59. Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation.
Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Abe M
Jpn J Cancer Res; 1996 Jan; 87(1):98-104. PubMed ID: 8609056
[TBL] [Abstract][Full Text] [Related]
60. The potentiation of the effect of radiation treatment by intratumoral delivery of cisplatin.
Yapp DT; Lloyd DK; Zhu J; Lehnert SM
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):413-20. PubMed ID: 9788424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
